Glaucoma
IOptima Receives CE Approval of its IOPtiMateTM Laser System for Treatment of Glaucoma
Published in Food and Drug Law Weekly, August 28th, 2009
IOPtima, a leading Israeli based company focused in the development and commercialization of advanced technologies for Glaucoma treatment, developed a novel CO2 laser based system (IOPtiMate TM) which enables the performance of a swift simplified, efficient and cost effective filtration procedure for the alleviation of Intra Ocular Pressure. The IOPtiMate TM is a breakthrough technology which enables practitioners to provide a safe and efficient...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
More Articles from Food and Drug Law Weekly
- Astellas Pharma US, Inc.
Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications - Defibrillators
Texas Law Firm Files Multiple Suits Against Medtronic as Deadline Approaches - Immunization
PharmAthene Reports Second Quarter 2009 Financial and Operational Results - Lupus
The Lupus Foundation of America Applauds New Legislation that Caps Out-of-Pocket Drug Costs - Regulatory Actions
Matrixx Initiatives, Inc. Reports Fiscal 2010 First Quarter Results; Includes Product Recall Costs and Impairment Charges - Advanced Cell Technology, Inc.
Dr. Robert Lanza is Featured Guest on Deepak Chopra's SIRIUS XM Stars Radio Show - More from this issue of Food and Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
